David M. Smadja - Concepedia

Author

David M. Smadja

Also Known As

Alex Serra Llovich, Anna Sediva, Catharina Schuetz, D M Smadja, D Smadja, D. M. Smadja, D. SMADJA, D. Smadja, D.-M. Smadja, D.M. SMADJA

396

Publications

15.8K

Citations

H-Index

132

Concepts

All Affiliations

Université Paris Cité Inserm Assistance Publique – Hôpitaux de Paris Hôpital Européen Georges-Pompidou Délégation Paris 5

About

David M. Smadja is an author at Université Paris Cité specializing in medicine, vascular biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	49	4.8K
2	Health Sciences	4	4	174
3	Education	1	1	27
4	Engineering	1	1	18
5	Natural Sciences	1	1	26

David M. Smadja

110

Publications

7.8K

Citations

H-Index

Page 1

	Year	Citations
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Paul Bastard, Lindsey B. Rosen, Qian Zhang, Science Viral DiagnosticsImmunodeficienciesViral ImmunityImmunologyViral Pathogenesis	2020	2.8K
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients David M. Smadja, Coralie L. Guérin, Richard Chocron, Angiogenesis	2020	258
Circulating Endothelial Cells David M. Smadja, Pascale Gaussem, Laëtitia Mauge, Circulation	2009	153
Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase David M. Smadja, Qun‐Ying Yue, Richard Chocron, European Respiratory Journal Virus EpidemiologyMrna VaccinesImmunologyCovid-19 EpidemiologyVenous Thrombosis Occurrence	2021	139
PAR-1 Activation on Human Late Endothelial Progenitor Cells Enhances Angiogenesis In Vitro With Upregulation of the SDF-1/CXCR4 System David M. Smadja, Ivan Bièche, Georges Uzan, Arteriosclerosis Thrombosis and Vascular Biology	2005	127
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality Aurélien Philippe, Richard Chocron, Nicolas Gendron, Angiogenesis ThrombosisVascular DiseaseVon Willebrand FactorCardiovascular DiseaseHematology	2021	124
Is COVID-19 a New Hematologic Disease? Benjamin Debuc, David M. Smadja Stem Cell Reviews and Reports	2020	114
Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support Flavien Vincent, Antoine Rauch, Valentin Loobuyck, Journal of the American College of Cardiology ThrombosisVascular DiseaseCardiovascular DiseaseMechanical Circulatory SupportArterial Pulsatility	2018	113
Bone Morphogenetic Proteins 2 and 4 Are Selectively Expressed by Late Outgrowth Endothelial Progenitor Cells and Promote Neoangiogenesis David M. Smadja, Ivan Bièche, Jean‐Sébastien Silvestre, Arteriosclerosis Thrombosis and Vascular Biology	2008	112
Thrombospondin-1 Is a Plasmatic Marker of Peripheral Arterial Disease That Modulates Endothelial Progenitor Cell Angiogenic Properties David M. Smadja, Clément d’Audigier, Ivan Bièche, Arteriosclerosis Thrombosis and Vascular Biology	2010	111

Page 1